Home |  Contact Us | Site Map

Investor Relations

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

Recent Releases

Jan 14, 2015
BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema

Jan 6, 2015
BioCryst to Present at J.P. Morgan Healthcare Conference

View all releases »

Investor Relations

Rob Bennett, Vice President Investor Relations & Operations
919.859.7910
investorrelations@biocryst.com

Proxy Online

For more information click here.

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)

Stock Information
NASDAQ : BCRX
$10.99   + 0.29
Jan 23, 2015
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.